Posaconazole 100 MG Delayed Release Oral Tablet — RxCUI 1482908
RxNorm drug concept · Semantic clinical drug
RxCUI 1482908
Semantic clinical drug · SCD
● Current RxNorm concept 29 FDA products
36 package NDCs
Snapshot Jul 14, 2026
What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.
🗂️ Key Facts
RxCUI1482908
Official namePosaconazole 100 MG Delayed Release Oral Tablet
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
FDA products mapped29
Package NDCs mapped36
Reported Medicaid activity (SDUD)8,228 prescriptions · 25 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026
📖 Skip the Codes — Read It in Plain English.
Our pharmacist-built guide to Posaconazole: what it is, how it’s used, side effects, and interactions.
📗 Our plain-language guide HelloPharmacist
- It treats invasive aspergillosis, a serious mold infection. It also helps prevent serious Aspergillus and Candida infections when your immune system is severely weakened. The oral...
- Delayed-release tablets can be taken with or without food. The oral suspension should be taken with a full meal. The injection is given by a clinician through a central line over a...
- The most common are diarrhea, nausea, vomiting, fever, headache, cough and low potassium. Let your care team know if they are bothersome or severe.
- Call right away for a racing or irregular heartbeat, fainting, signs of liver trouble, rising blood pressure or swelling, or severe vomiting and diarrhea. Those last two can keep t...
🕸️ Concept Web — How Posaconazole 100 MG Delayed Release Oral Tablet Connects
One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept
Posaconazole 100 MG Delayed Release Oral Tablet
RxCUI 1482908 Semantic clinical drug · SCD
Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.
-
Ingredients 1
The active substance itself — no strength, form, or brand attached yet.
-
Posaconazole
282446IN
-
Posaconazole
-
Brand names 1
The same medicine's trade names. A brand name alone says nothing about strength or form.
-
Noxafil
356772BN
-
Noxafil
-
Dose forms 9
The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
-
Posaconazole Delayed Release Oral Tablet
1482907SCDF -
Posaconazole Oral Product
1165109SCDG -
Posaconazole Pill
1482906SCDG -
Posaconazole Delayed Release Oral Tablet [Noxafil]
1482910SBDF -
Noxafil Oral Product
1178134SBDG -
Noxafil Pill
1482911SBDG -
Delayed Release Oral Tablet
10312DF -
Oral Product
1151131DFG - +1 more in this family
-
Posaconazole Delayed Release Oral Tablet
-
Clinical & branded drugs 3
Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
-
Posaconazole 100 MG
1482905SCDC -
Posaconazole 100 MG Delayed Release Oral Tablet [Noxafil]
1482912SBD -
Posaconazole 100 MG [Noxafil]
1482909SBDC
-
Posaconazole 100 MG
Showing up to 8 concepts per family — 13 of 14 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.
🔀 Generic ⇄ Brand Crosswalk
The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.
Generic (Clinical) Concepts
-
Posaconazole 100 MG
SCDC · 1482905 -
Posaconazole Delayed Release Oral Tablet
SCDF · 1482907 -
Posaconazole Oral Product
SCDG · 1165109 -
Posaconazole Pill
SCDG · 1482906
Brand-Name Concepts
-
Posaconazole 100 MG Delayed Release Oral Tablet [Noxafil]
SBD · 1482912 -
Posaconazole 100 MG [Noxafil]
SBDC · 1482909 -
Posaconazole Delayed Release Oral Tablet [Noxafil]
SBDF · 1482910 -
Noxafil Oral Product
SBDG · 1178134 -
Noxafil Pill
SBDG · 1482911 -
Noxafil
BN · 356772
📦 FDA Products & Package NDCs
29 products · 36 package NDCs
36 package NDCs map to RxCUI 1482908 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
| Package NDC | Package | Brand / generic name | Labeler | Marketing start |
|---|---|---|---|---|
| 00085-1328-01 | 1 BOTTLE, GLASS in 1 CARTON (0085-1328-01) / 105 mL in 1 BO... | NOXAFIL | Merck Sharp & Dohme LLC | 2006-09-15 |
| 00085-2224-02 | 8 PACKET in 1 CARTON (0085-2224-02) / 1 POWDER, FOR SUSPENS... | NOXAFIL | Merck Sharp & Dohme LLC | 2021-06-08 |
| 00085-4324-02 | 60 TABLET, COATED in 1 BOTTLE (0085-4324-02) | NOXAFIL | Merck Sharp & Dohme LLC | 2013-11-25 |
| 00085-4331-01 | 1 VIAL, GLASS in 1 CARTON (0085-4331-01) / 16.7 mL in 1 VIA... | NOXAFIL | Merck Sharp & Dohme LLC | 2014-03-13 |
| 00254-1016-36 | 1 BOTTLE, GLASS in 1 CARTON (0254-1016-36) / 105 mL in 1 BO... | POSACONAZOLE | ENDO USA, Inc. | 2023-03-29 |
| 00254-2045-02 | 60 TABLET, COATED in 1 BOTTLE (0254-2045-02) | POSACONAZOLE | ENDO USA, Inc. | 2019-08-30 |
| 00406-7711-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0406-7711-60) | POSACONAZOLE | SpecGx LLC | 2022-05-10 |
| 00527-2133-30 | 24 TABLET, DELAYED RELEASE in 1 CARTON (0527-2133-30) | POSACONAZOLE | Lannett Company Inc. | 2021-01-31 |
| 00527-2133-35 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (0527-2133-35) | POSACONAZOLE | Lannett Company Inc. | 2019-08-28 |
| 00527-2133-43 | 1000 TABLET, DELAYED RELEASE in 1 BOTTLE (0527-2133-43) | POSACONAZOLE | Lannett Company Inc. | 2019-08-28 |
| 00904-7149-04 | 30 BLISTER PACK in 1 CARTON (0904-7149-04) / 1 TABLET, DELA... | POSACONAZOLE | Major Pharmaceuticals | 2021-02-03 |
| 00904-7149-10 | 20 BLISTER PACK in 1 CARTON (0904-7149-10) / 1 TABLET, DELA... | POSACONAZOLE | Major Pharmaceuticals | 2021-02-03 |
| 16714-0535-01 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (16714-535-01) | Posaconazole | NorthStar RxLLC | 2023-04-02 |
| 17856-2133-01 | 100 POUCH in 1 BOX, UNIT-DOSE (17856-2133-1) / 1 TABLET, DE... | POSACONAZOLE | ATLANTIC BIOLOGICALS CORP. | 2024-05-09 |
| 17856-2133-05 | 59 POUCH in 1 BOX (17856-2133-5) / 1 TABLET, DELAYED RELEAS... | POSACONAZOLE | ATLANTIC BIOLOGICALS CORP. | 2026-04-20 |
| 31722-0677-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (31722-677-60) | Posaconazole | Camber Pharmaceuticals, Inc. | 2022-12-08 |
| 42291-0919-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (42291-919-60) | Posaconazole | AvKARE | 2023-04-20 |
| 43598-0470-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (43598-470-60) | Posaconazole | Dr.Reddys Laboratories Inc | 2022-04-07 |
| 50268-0683-12 | 20 BLISTER PACK in 1 BOX (50268-683-12) / 1 TABLET, DELAYED... | Posaconazole | AvPAK | 2022-05-09 |
| 51407-0676-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (51407-676-60) | POSACONAZOLE | Golden State Medical Supply, Inc. | 2022-09-12 |
| 59651-0596-60 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (59651-596-60) | POSACONAZOLE | Aurobindo Pharma Limited | 2024-07-18 |
| 60687-0523-21 | 30 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-523-21) / 1 TABL... | Posaconazole | American Health Packaging | 2020-06-11 |
| 60687-0523-94 | 20 BLISTER PACK in 1 BOX, UNIT-DOSE (60687-523-94) / 1 TABL... | Posaconazole | American Health Packaging | 2022-03-03 |
| 62135-0429-60 | 60 TABLET in 1 BOTTLE (62135-429-60) | POSACONAZOLE | Chartwell RX, LLC | 2022-12-12 |
| 63629-2236-01 | 60 TABLET, COATED in 1 BOTTLE (63629-2236-1) | POSACONAZOLE | Bryant Ranch Prepack | 2024-09-05 |
| 69238-1476-03 | 30 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1476-3) | Posaconazole | Amneal Pharmaceuticals NY LLC | 2022-12-30 |
| 69238-1476-06 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (69238-1476-6) | Posaconazole | Amneal Pharmaceuticals NY LLC | 2022-12-30 |
| 70377-0038-11 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (70377-038-11) | POSACONAZOLE | Biocon Phama Inc. | 2022-03-08 |
| 70748-0258-07 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (70748-258-07) | POSACONAZOLE | Lupin Pharmaceuticals, Inc. | 2021-02-17 |
| 71335-2665-01 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2665-1) | Posaconazole | Bryant Ranch Prepack | 2025-06-26 |
| 71335-2930-01 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (71335-2930-1) | Posaconazole | Bryant Ranch Prepack | 2025-11-11 |
| 72162-2243-02 | 20 TABLET, DELAYED RELEASE in 1 BOTTLE (72162-2243-2) | Posaconazole | Bryant Ranch Prepack | 2024-01-19 |
| 72162-2243-06 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (72162-2243-6) | Posaconazole | Bryant Ranch Prepack | 2024-01-19 |
| 72205-0168-60 | 60 TABLET, COATED in 1 BOTTLE (72205-168-60) | posaconazole | Novadoz Pharmaceuticals LLC | 2025-04-01 |
| 72319-0023-02 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (72319-023-02) | Posaconazole | i3 Pharmaceuticals, LLC | 2023-09-15 |
| 73141-0023-02 | 60 TABLET, DELAYED RELEASE in 1 BOTTLE (73141-023-02) | Posaconazole | A2A Integrated Pharmaceuticals | 2024-05-16 |
Observed labelers:
Bryant Ranch Prepack (5) ·
Merck Sharp & Dohme LLC (4) ·
Lannett Company Inc. (3) ·
American Health Packaging (2) ·
Amneal Pharmaceuticals NY LLC (2) ·
ATLANTIC BIOLOGICALS CORP. (2)
· +16 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.
🗃️ Sources & Limits
Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
- A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
- Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
- Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
- Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.
Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.